About Liveyon: Our Company History

Liveyon grew organically from the developing field of regenerative medicine and interest of the founders which suffered from degenerative diseases. As research and clinical studies continued to support the benefits of using regenerative medicine to help the body heal itself, demand for high-quality products suitable for use in the clinical practice of regenerative medicine therapies began to increase.

A growing number of pain management specialists, orthopedic surgeons, plastic surgeons, and other doctors and physicians were searching the market for a reliable source of a high quality regenerative medicine product. We partnered with a laboratory that meets and exceeds FDA standards in order to provide the best quality product from the safest source, screened and controlled under independent testing. LIVEYON stands by this product and are excited about making this product directly available to physicians.

Why Liveyon Is Different 

Liveyon distributes umbilical cord derived products to physicians for use in regenerative medicine therapies. The umbilical cord is rich in growth factors, cells and life as it has helped sustain the life of a healthy child for 9 months.

A Safe Product

We provide our customers with umbilical cord derived cells and growth factors that are ethically collected with informed consent. Umbilical cord donation is regulated by the American Association of Tissue Banks (AATB) for quality, safety and ethics. The cells are sourced from the umbilical cord of healthy donor volunteers painlessly and noninvasively. Each donor is carefully screened for pathogens in order to assure the product is safe. In addition, presently there is no documentation of umbilical cord cells causing a malignancy or transforming into a malignant state following their use as a therapy. 

These cells need no donor-patient matching as just like all MSCs they are HLA-DR negative, and can be used for any patient with minimal to no side effects. 

Easy For Physicians to Use

Liveyon delivers uniform single doses with high cell-count, consistent concentrations. These can applied according to your specific protocols or patients’ needs. Our regenerative medicine product can be delivered either cryopreserved on dry ice or in cryogenic dry vapor dewars. Our product is strictly compliant with FDA standards under Current Good Manufacturing Practice (CGMP) regulations. We take pride in the quality and reliability of our product.

Consistent Concentrations for Precision and Control

From the beginning, our goal has been to provide doctors with the highest quality stem cell product. Our cells are safe, FDA-compliant, and easy to use. We deliver them directly to your medical practice in consistent concentrations for precise, controlled treatments. Production is strictly compliant with FDA standards under Current Good Manufacturing Practice (CGMP) regulations. We take pride in the quality and reliability of our product.

Specialties We Serve  

Liveyon serves a growing population of medical doctors who are choosing to include regenerative therapies in their practice. As research and clinical trials suggest an increasing array of benefits from the use of stem cells and other regenerative medicine products.

Liveyon provides MSCs to practitioners in a number of specialties, and for the treatment of conditions like:

Chronic pain
Respiratory disorders and lung disease
athletic injuries
Spinal cord injuries and other orthopedic conditions
Parkinson’s, ALS, Alzheimer’s and other neurological diseases
Cosmetic/aesthetic issues (treated by cosmetic dermatologists)
Diabetes
Heart diseases and cardiovascular conditions
Rheumatoid arthritis, Crohn’s disease, lupus, and other autoimmune disorders
Orthodontics
Dermatological disorders
AND MORE...
To learn more or place an order, contact us online or call us at 844-LIVEYON.
 

Medical Professional Viewing Only (Disclaimer)


This site was intended for education purposes only and strictly for use by medical professionals. The FDA recently re-confirmed, there is only one registered stem cell product, and while there is enormous promise in stem cell therapies, and thousands of ongoing experimental applications trying to establish efficacy, these are not at the point where they would meet the scientific standard.

The FDA has stated:

Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.

http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194655.htm

This site is not intended for consumers.

If you are considering stem cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the stem cells are your own. Even if the cells are yours, there are safety risks, including risks introduced when the cells are manipulated after removal.

“There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body.” Cells in a different environment may multiply, form tumors, or may leave the site you put them in and migrate somewhere else.

If you are considering having stem cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a stem cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate stem cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their stem cell products.

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm286155.htm

Stem cell therapies have enormous promise, but the science in each use is still in the developmental stage.  Professional judgment and expertise is needed in using stem cells for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies to consult the national health data bases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.